ArticleFrontiers in immunology2025

Fruquintinib and sintilimab plus SOX as perioperative therapy for locally resectable advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase II clinical trial.

Xiangyu Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.